Stablecoin Development

NBY · NYSE

$0.83−$0.0084 (−1.00%)TodayMarket closed ·
Prev close $0.8384

Latest news

  • Press releaseGlobe Newswire

    Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments

  • Press releaseGlobe Newswire

    NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Crude Oil Gains 2%; D.R. Horton Earnings Top Views

  • NewsAvi Kapoor

    Dow Falls Over 500 Points; 3M Posts Upbeat Earnings

  • NewsAvi Kapoor

    J.B. Hunt Posts Mixed Q4 Results, Joins QXO And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • NewsAvi Kapoor

    H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Why RF Industries Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    US Stocks Lower; Dow Tumbles Over 250 Points

  • NewsAvi Kapoor

    Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

  • NewsAvi Kapoor

    Cybin, Xpeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Carnival Posts Strong Q4 Earnings, Joins Amicus Therapeutics, Biomarin Pharmaceutical And Other Big Stocks Moving Higher On Friday

  • NewsAvi Kapoor

    Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday

  • NewsAvi Kapoor

    Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday

  • NewsAvi Kapoor

    Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Dow Falls Over 100 Points; Paychex Shares Fall After Q1 Results

  • Press releaseGlobe Newswire

    NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    Crude Oil Gains Over 1%; UP Fintech Shares Plunge

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsAvi Kapoor

    Dow Surges Over 100 Points; JM Smucker Earnings Miss Views

  • News

    Market-Moving News for August 27th

  • NewsAvi Kapoor

    Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Down 1%; Lowe's Posts Upbeat Earnings

  • NewsAvi Kapoor

    Dow Surges 100 Points; Target Shares Fall After Q2 Results

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • NewsAvi Kapoor

    Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

  • Press releaseBusiness Wire

    NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders

  • Press releaseBusiness Wire

    NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

  • Press releaseBusiness Wire

    NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

  • Press releaseBusiness Wire

    NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

  • Press releaseBusiness Wire

    NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024

  • Press releaseBusiness Wire

    Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand

  • Press releaseBusiness Wire

    NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results

  • Press releaseBusiness Wire

    NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseBusiness Wire

    NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.